Assessing Risk and Benefit Communication in Direct-to-Consumer Medication Website Advertising
- 1 January 2005
- journal article
- other
- Published by Springer Science and Business Media LLC in Drug Information Journal
- Vol. 39 (1), 3-12
- https://doi.org/10.1177/009286150503900102
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- Placement of Benefits and Risks in Prescription Drug Manufacturers’ Websites and Information Source ExpectationsDrug Information Journal, 2005
- The Effects of Print Format in Direct-To-Consumer Prescription Drug Advertisements on Risk Knowledge and PreferenceDrug Information Journal, 2002
- Direct-to-Consumer (DTC) Advertising of Prescription Medications on the World Wide Web: Assessing the Communication of RisksProceedings of the Human Factors and Ergonomics Society Annual Meeting, 2001
- Direct-To-Consumer Prescription Drug Advertising: Trends, Impact, And ImplicationsHealth Affairs, 2000
- A Task-Analytic Approach to the Temporal and Spatial Placement of Product WarningsHuman Factors: The Journal of the Human Factors and Ergonomics Society, 1993